{
  "ticker": "LLY",
  "target_date": "2025-11-20",
  "actual_date": "2025-11-20",
  "collected_at": "2025-12-08T12:33:41.508647",
  "price": {
    "open": 1045.5,
    "high": 1057.0,
    "low": 1038.25,
    "close": 1043.2900390625,
    "volume": 3135700,
    "change_1d_pct": -0.6,
    "change_7d_pct": 5.68,
    "change_30d_pct": 22.15
  },
  "technicals": {
    "rsi_14": 89.92,
    "sma_20": 936.49,
    "sma_50": 848.83,
    "macd": 60.308,
    "macd_signal": 51.956,
    "macd_histogram": 8.352,
    "bb_upper": 1106.06,
    "bb_lower": 766.92,
    "price_vs_sma20_pct": 11.4,
    "price_vs_sma50_pct": 22.91,
    "volume_ratio": 0.71
  },
  "fundamentals": {
    "market_cap": 891846721536,
    "pe_ratio": 48.74363,
    "forward_pe": 43.903683,
    "price_to_book": 37.456985,
    "price_to_sales": 15.009252,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.53,
    "pct_from_52w_low": 59.49
  },
  "macro": {
    "spy": {
      "price": 652.53,
      "change_1d_pct": -1.52,
      "change_7d_pct": -4.51
    },
    "vix": {
      "level": 26.42,
      "signal": "HIGH_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.11
    },
    "dollar_index": {
      "level": 100.16
    },
    "gold": {
      "price": 4056.5
    },
    "regime": "BEAR_HIGH_VOL"
  },
  "news": [
    {
      "headline": "VIPC Signs MOU with AstraZeneca, Eli Lilly, Merck to Develop the Virginia Center for Advanced Pharmaceutical Manufacturing to Train Workforce of the Future",
      "source": "Yahoo",
      "datetime": 1763656380,
      "summary": "A Memorandum of Understanding (MOU) signed by the Virginia Innovation Partnership Corporation (VIPC) and AstraZeneca, Eli Lilly (Lilly), and Merck to develop the Virginia Center for Advanced Pharmaceutical Manufacturing (APM) was executed by Governor Glenn Youngkin at a statewide gathering with key ",
      "url": "https://finnhub.io/api/news?id=f5b8dd330fb63b7d7d18eb5bdce1105353fcf5a2c359fcfad59cf458e8d91ad4"
    },
    {
      "headline": "VKTX Completes Enrollment in First Late-Stage Study on Obesity Drug",
      "source": "Yahoo",
      "datetime": 1763656200,
      "summary": "Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study, surpassing targets and marking rapid progress for its VK2735 program.",
      "url": "https://finnhub.io/api/news?id=98c70c7c5eeab834aba20473a0aa990bd63730604dc53e9390a9531a7403f531"
    },
    {
      "headline": "Novo Nordisk Alzheimer's studies could yield answers on GLP-1 benefit",
      "source": "Yahoo",
      "datetime": 1763650783,
      "summary": "STORY: Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a class being used by millions for diabetes and weight loss - can slow progress of Alzheimer's disease.Two trials have been described by Novo as a \"lottery ticket\".They'r",
      "url": "https://finnhub.io/api/news?id=ca8b7a730a85a6cfab818628a7c17f54bca4458d8f4a8c7d92e940c4542b50d2"
    },
    {
      "headline": "Here's Why Eli Lilly (LLY) is a Strong Growth Stock",
      "source": "Yahoo",
      "datetime": 1763649903,
      "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
      "url": "https://finnhub.io/api/news?id=efc588e808767d9a68285ff6ef242555067043dab9d9a43bcdc614ab861c3b1b"
    },
    {
      "headline": "Novo Nordisk: Will Wegovy And Pipeline Spark Rally?",
      "source": "SeekingAlpha",
      "datetime": 1763643080,
      "summary": "Discover 5+ factors making Novo Nordisk a strong long-term stock pick despite market skepticism.",
      "url": "https://finnhub.io/api/news?id=194d7708f918ec1df5a237a1ccc54ff69f6767151c5969241794ff371de89988"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-20",
      "description": "xslF345X05/form4-11202025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000081/xslF345X05/form4-11202025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-19",
      "description": "xslF345X05/form4-11192025_041102.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000079/xslF345X05/form4-11192025_041102.xml"
    },
    {
      "form": "4",
      "date": "2025-11-18",
      "description": "xslF345X05/wk-form4_1763501994.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000269/xslF345X05/wk-form4_1763501994.xml"
    },
    {
      "form": "4",
      "date": "2025-11-18",
      "description": "xslF345X05/wk-form4_1763501198.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000126238825000008/xslF345X05/wk-form4_1763501198.xml"
    },
    {
      "form": "4",
      "date": "2025-11-18",
      "description": "xslF345X05/wk-form4_1763501099.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000266/xslF345X05/wk-form4_1763501099.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}